TY - JOUR
T1 - Exploiting substrate recognition for selective inhibition of protein kinases
AU - Licht-Murava, Avital
AU - Eldar-Finkelman, Hagit
PY - 2012/7
Y1 - 2012/7
N2 - Protein kinases are potential targets of drugs to treat many human diseases. Intensive efforts have been made to develop protein kinase inhibitors, but a major challenge is achieving specificity. Exploiting regulatory elements outside the ATP binding pocket, such as the substrate binding site, may provide an alternative that allows generation of competitive inhibitors with improved selectivity. Indepth understanding of substrate recognition by protein kinase is essential for design and refinement of competitive inhibitors. Here we described strategies for specifically targeting protein kinases and highlight our current progress in the development of substrate competitive inhibitors for glycogen synthase kinase-3 (GSK-3).
AB - Protein kinases are potential targets of drugs to treat many human diseases. Intensive efforts have been made to develop protein kinase inhibitors, but a major challenge is achieving specificity. Exploiting regulatory elements outside the ATP binding pocket, such as the substrate binding site, may provide an alternative that allows generation of competitive inhibitors with improved selectivity. Indepth understanding of substrate recognition by protein kinase is essential for design and refinement of competitive inhibitors. Here we described strategies for specifically targeting protein kinases and highlight our current progress in the development of substrate competitive inhibitors for glycogen synthase kinase-3 (GSK-3).
KW - GSK-3
KW - Inhibitor design
KW - Protein kinase
KW - Substrate recognition
UR - http://www.scopus.com/inward/record.url?scp=84861722493&partnerID=8YFLogxK
U2 - 10.2174/138161212800672741
DO - 10.2174/138161212800672741
M3 - מאמר
AN - SCOPUS:84861722493
VL - 18
SP - 2914
EP - 2920
JO - Current Pharmaceutical Design
JF - Current Pharmaceutical Design
SN - 1381-6128
IS - 20
ER -